A case of pure-type ovarian squamous cell carcinoma for which combination chemotherapy consisting of paclitaxel and carboplatin was not effective.
BACKGROUND
There has been no report on the effectiveness of combination chemotherapy consisting of paclitaxel and carboplatin for pure-type ovarian squamous cell carcinoma (POSCC).


METHODS
A 56-year-old Japanese woman diagnosed as having pT2c pN1 M0 pure-type ovarian squamous cell carcinoma was treated with combination chemotherapy consisting of paclitaxel and carboplatin every 3 weeks. Four months after the initial chemotherapy, multiple lung tumors appeared and a new tumor in the internal iliac area appeared. She died of disease 12 months after the first treatment.


CONCLUSIONS
Adjuvant chemotherapy consisting of paclitaxel and carboplatin for ovarian squamous cell carcinoma were not effective in this case.
Todo
Yukiharu
Y
Department of Obstetrics and Gynecology, Hokkaido University School of Medicine, Kita-15, Nishi-7, Kita-Ku, Sapporo 060-8638, Japan. yukiharu@med.hokudai.ac.jp
Minobe
Shinichiro
S
Sasaki
Mizue
M
Yamamoto
Ritsu
R
Sakuragi
Noriaki
N
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017239:Paclitaxel / Q000008:administration & dosage; D017211:Treatment Failure
D016190:Carboplatin; D017239:Paclitaxel